ly 255283 has been researched along with Breast Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, H; Kim, JH; Lee, JE; Park, GS | 1 |
| Choi, JA; Kim, H; Kim, JH | 1 |
| Choi, JA; Kim, EY; Kim, H; Kim, JH; Ko, J; Lee, JW; Seo, JM | 1 |
3 other study(ies) available for ly 255283 and Breast Cancer
| Article | Year |
|---|---|
A leukotriene B4 receptor-2 is associated with paclitaxel resistance in MCF-7/DOX breast cancer cells.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Leukotriene Antagonists; Mice; Mice, Nude; Paclitaxel; Receptors, Leukotriene B4; RNA, Small Interfering; Tetrazoles; Xenograft Model Antitumor Assays | 2013 |
Ras promotes transforming growth factor-β (TGF-β)-induced epithelial-mesenchymal transition via a leukotriene B4 receptor-2-linked cascade in mammary epithelial cells.
Topics: Breast Neoplasms; Cell Line; Epithelial-Mesenchymal Transition; Female; Humans; Mammary Glands, Human; NADPH Oxidase 1; NADPH Oxidases; NF-kappa B; Proto-Oncogene Proteins p21(ras); Reactive Oxygen Species; Receptors, Leukotriene B4; RNA, Small Interfering; Signal Transduction; Tetrazoles; Transforming Growth Factor beta | 2014 |
Pro-survival of estrogen receptor-negative breast cancer cells is regulated by a BLT2-reactive oxygen species-linked signaling pathway.
Topics: Breast Neoplasms; Cells, Cultured; Female; Humans; Leukotriene B4; NADPH Oxidase 1; NADPH Oxidases; Reactive Oxygen Species; Receptors, Estrogen; Receptors, Leukotriene B4; Signal Transduction; Tetrazoles | 2010 |